India may not immediately import an antibody from Australia to combat the Nipah virus as the affected patients in Kerala are out of danger. However, the government and the Indian Council of Medical Research (ICMR) are in talks with the Serum Institute of India (SII) for local manufacturing. Given the recurring outbreaks in the last five years, the government is considering domestic manufacturing of monoclonal antibodies (MABs) — that are used on compassionate grounds — for treating Nipah virus infections.
Serum Institute of India, the world’s biggest vaccine maker, did not comment on the development.
Kerala Health Minister Veena George

)